Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-02

AUTHORS

Marc C. Chamberlain, Howard Colman, Bryan T. Kim, Jeffrey Raizer

ABSTRACT

There is no standard therapy for recurrent anaplastic glioma (AG). Salvage therapies include alkylator-based chemotherapy, re-resection with or without carmustine implants, re-irradiation and bevacizumab. Bendamustine is a novel bifunctional alkylator with CNS penetration never previously evaluated in AG. Assess response and toxicity of bendamustine in recurrent AG in a phase II trial. Adults with radiation and temozolomide refractory recurrent AG were treated with bendamustine. A cycle of bendamustine was defined as two consecutive days of treatment (100 mg/m2/day) administered once every 4 weeks. Success of treatment was defined as progression free survival (PFS) at 6 months of 40 % or better. Twenty-six adults [16 males; 10 females: median age 40 years (range 30-65)] were treated, 12 at first recurrence and 17 at second recurrence. Prior salvage therapy included re-resection (14), chemotherapy (11) and re-radiation (2). Grade 3 treatment-related toxicities included lymphopenia (11 patients; Grade 4 in 3), myalgia, pneumonia, diarrhea, leukopenia, allergic reaction and thrombocytopenia in one patient each. One patient discontinued therapy due to toxicity. There were five instances of bendamustine dose delays all due to lymphopenia. There were no dose reductions due to toxicity. The median number of cycles of therapy was 3 (range 1-8). Best radiographic response was progressive disease in 12 (46 %), stable disease in 13 (50 %) and partial response in 1 (4 %). Median, 6- and 12-month PFS was 2.7 months (range 1-52), 27 and 8 % respectively. In patients with recurrent AG refractory to Z, bendamustine has manageable toxicity and modest single agent activity though not meeting pre-specified study criteria. More... »

PAGES

507-516

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-016-2241-7

DOI

http://dx.doi.org/10.1007/s11060-016-2241-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1083842670

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28204914


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bendamustine Hydrochloride", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Temozolomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Cancer Research Center, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Ave E, MS: G4-940, 98109, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Utah", 
          "id": "https://www.grid.ac/institutes/grid.223827.e", 
          "name": [
            "Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Colman", 
        "givenName": "Howard", 
        "id": "sg:person.01261043223.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261043223.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Washington", 
          "id": "https://www.grid.ac/institutes/grid.34477.33", 
          "name": [
            "Department of Neurology, University of Washington, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Bryan T.", 
        "id": "sg:person.016114330577.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016114330577.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern University", 
          "id": "https://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Department of Neurology, Northwestern University, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raizer", 
        "givenName": "Jeffrey", 
        "id": "sg:person.010677556177.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00401-014-1370-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000424731", 
          "https://doi.org/10.1007/s00401-014-1370-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.18.7252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000657227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00401-007-0243-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001430701", 
          "https://doi.org/10.1007/s00401-007-0243-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00401-007-0243-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001430701", 
          "https://doi.org/10.1007/s00401-007-0243-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.5520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001482068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.3273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007363870", 
          "https://doi.org/10.1038/ng.3273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)90755-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007598090"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)90755-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007598090"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.43.2229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011620673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2015.12.028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012801617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-319-12048-5_6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013471351", 
          "https://doi.org/10.1007/978-3-319-12048-5_6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.03.4157", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019017095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.6497", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024766199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nor091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028232474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-008-9722-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029000688", 
          "https://doi.org/10.1007/s11060-008-9722-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1402121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034690235"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2596", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034823106", 
          "https://doi.org/10.1038/nrd2596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-07-1061", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043780748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.43.2674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044364683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1407279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044684277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.6941", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045298298"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)70011-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046267258"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.49.3726", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046571868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-014-1411-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046834783", 
          "https://doi.org/10.1007/s11060-014-1411-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bpa.12171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048224406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-011-0612-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050266838", 
          "https://doi.org/10.1007/s11060-011-0612-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-014-1714-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051597847", 
          "https://doi.org/10.1007/s11060-014-1714-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejme1506813", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052619643"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.08.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203783"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.12.097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.8.2572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.9.2762", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549908"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.7.1277", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0132", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078785484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0132", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078785484"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-02", 
    "datePublishedReg": "2017-02-01", 
    "description": "There is no standard therapy for recurrent anaplastic glioma (AG). Salvage therapies include alkylator-based chemotherapy, re-resection with or without carmustine implants, re-irradiation and bevacizumab. Bendamustine is a novel bifunctional alkylator with CNS penetration never previously evaluated in AG. Assess response and toxicity of bendamustine in recurrent AG in a phase II trial. Adults with radiation and temozolomide refractory recurrent AG were treated with bendamustine. A cycle of bendamustine was defined as two consecutive days of treatment (100\u00a0mg/m2/day) administered once every 4\u00a0weeks. Success of treatment was defined as progression free survival (PFS) at 6\u00a0months of 40\u2009% or better. Twenty-six adults [16 males; 10 females: median age 40 years (range 30-65)] were treated, 12 at first recurrence and 17 at second recurrence. Prior salvage therapy included re-resection (14), chemotherapy (11) and re-radiation (2). Grade 3 treatment-related toxicities included lymphopenia (11 patients; Grade 4 in 3), myalgia, pneumonia, diarrhea, leukopenia, allergic reaction and thrombocytopenia in one patient each. One patient discontinued therapy due to toxicity. There were five instances of bendamustine dose delays all due to lymphopenia. There were no dose reductions due to toxicity. The median number of cycles of therapy was 3 (range 1-8). Best radiographic response was progressive disease in 12 (46\u2009%), stable disease in 13 (50\u2009%) and partial response in 1 (4\u2009%). Median, 6- and 12-month PFS was 2.7\u00a0months (range 1-52), 27 and 8\u2009% respectively. In patients with recurrent AG refractory to Z, bendamustine has manageable toxicity and modest single agent activity though not meeting pre-specified study criteria.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-016-2241-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "131"
      }
    ], 
    "name": "Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial", 
    "pagination": "507-516", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "758cb173f56b40113184fef8e77c79ba619fa19096ba9a6aa1b27f6712dd542e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28204914"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-016-2241-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1083842670"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-016-2241-7", 
      "https://app.dimensions.ai/details/publication/pub.1083842670"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89804_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11060-016-2241-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-016-2241-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-016-2241-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-016-2241-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-016-2241-7'


 

This table displays all metadata directly associated to this object as RDF triples.

275 TRIPLES      21 PREDICATES      79 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-016-2241-7 schema:about N06757b4ac2304d57a498323a897b1d1a
2 N0da62ab170f948288769e111dc5dedb9
3 N2dfbb54b7f4d4c8e8438cbf920a84faf
4 N2e82a38ee52843a4b8a220aad9edd12a
5 N3f7383e6ba1f40748f64d639924d9a3e
6 N4ab70825768f4557bdd0739fbe538421
7 N501b2fe6bd0c4e11be2108c5ffa065a6
8 N89f9b9fb29554d4d9dfc7a24d81e4bae
9 N90f2e1fdcad049cdbf0debf679ec0f69
10 N917654901e77470693adcee716cf6951
11 N9314a894c9474a45bda3344f7b4e54c2
12 Nbd58bb43b0a64950a00bd11eb67424d3
13 Nc5593eac880541d082101a1e80920cb9
14 Ncbf392fe3f4b471fb9c25cbe19258974
15 Ncc381f5c09184fcbb384c11656193680
16 Nd9c763ca63df4dc9a57d030959a4a27b
17 Ne836460e828c448da132b04a9896b977
18 Nfcd781283a7a4a1caf6d0fc80e5e41c4
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author Nd6380d59460442a0a4ceda1cfbca4de4
22 schema:citation sg:pub.10.1007/978-3-319-12048-5_6
23 sg:pub.10.1007/s00401-007-0243-4
24 sg:pub.10.1007/s00401-014-1370-3
25 sg:pub.10.1007/s11060-008-9722-2
26 sg:pub.10.1007/s11060-011-0612-7
27 sg:pub.10.1007/s11060-014-1411-8
28 sg:pub.10.1007/s11060-014-1714-9
29 sg:pub.10.1038/ng.3273
30 sg:pub.10.1038/nrd2596
31 https://doi.org/10.1016/j.cell.2015.12.028
32 https://doi.org/10.1016/s0140-6736(95)90755-6
33 https://doi.org/10.1016/s1470-2045(14)70011-7
34 https://doi.org/10.1056/nejme1506813
35 https://doi.org/10.1056/nejmoa1402121
36 https://doi.org/10.1056/nejmoa1407279
37 https://doi.org/10.1093/neuonc/nor091
38 https://doi.org/10.1111/bpa.12171
39 https://doi.org/10.1158/1078-0432.ccr-07-1061
40 https://doi.org/10.1200/jco.1990.8.7.1277
41 https://doi.org/10.1200/jco.1999.17.8.2572
42 https://doi.org/10.1200/jco.1999.17.9.2762
43 https://doi.org/10.1200/jco.2003.08.045
44 https://doi.org/10.1200/jco.2003.12.097
45 https://doi.org/10.1200/jco.2005.03.4157
46 https://doi.org/10.1200/jco.2008.18.7252
47 https://doi.org/10.1200/jco.2009.23.6497
48 https://doi.org/10.1200/jco.2009.25.6941
49 https://doi.org/10.1200/jco.2009.26.5520
50 https://doi.org/10.1200/jco.2012.43.2229
51 https://doi.org/10.1200/jco.2012.43.2674
52 https://doi.org/10.1200/jco.2013.49.3726
53 https://doi.org/10.6004/jnccn.2013.0132
54 schema:datePublished 2017-02
55 schema:datePublishedReg 2017-02-01
56 schema:description There is no standard therapy for recurrent anaplastic glioma (AG). Salvage therapies include alkylator-based chemotherapy, re-resection with or without carmustine implants, re-irradiation and bevacizumab. Bendamustine is a novel bifunctional alkylator with CNS penetration never previously evaluated in AG. Assess response and toxicity of bendamustine in recurrent AG in a phase II trial. Adults with radiation and temozolomide refractory recurrent AG were treated with bendamustine. A cycle of bendamustine was defined as two consecutive days of treatment (100 mg/m<sup>2</sup>/day) administered once every 4 weeks. Success of treatment was defined as progression free survival (PFS) at 6 months of 40 % or better. Twenty-six adults [16 males; 10 females: median age 40 years (range 30-65)] were treated, 12 at first recurrence and 17 at second recurrence. Prior salvage therapy included re-resection (14), chemotherapy (11) and re-radiation (2). Grade 3 treatment-related toxicities included lymphopenia (11 patients; Grade 4 in 3), myalgia, pneumonia, diarrhea, leukopenia, allergic reaction and thrombocytopenia in one patient each. One patient discontinued therapy due to toxicity. There were five instances of bendamustine dose delays all due to lymphopenia. There were no dose reductions due to toxicity. The median number of cycles of therapy was 3 (range 1-8). Best radiographic response was progressive disease in 12 (46 %), stable disease in 13 (50 %) and partial response in 1 (4 %). Median, 6- and 12-month PFS was 2.7 months (range 1-52), 27 and 8 % respectively. In patients with recurrent AG refractory to Z, bendamustine has manageable toxicity and modest single agent activity though not meeting pre-specified study criteria.
57 schema:genre research_article
58 schema:inLanguage en
59 schema:isAccessibleForFree false
60 schema:isPartOf N4f8d438854bb4dc6a7585f1b155b744e
61 Ne4f8d9eade2e49ffb93c94855dc0fcdc
62 sg:journal.1094205
63 schema:name Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial
64 schema:pagination 507-516
65 schema:productId N07987ca76607441fad2e688ba3c2bff6
66 N3ef53c6ca5b149a5a19f33491b89b1d8
67 N55333de7ad3544798e6776a91f09dc00
68 Nba6f993506cf4e3da3c70b4fc1e6facf
69 Ne31394ef79e5490ea84f2c7e88c7832d
70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083842670
71 https://doi.org/10.1007/s11060-016-2241-7
72 schema:sdDatePublished 2019-04-11T09:56
73 schema:sdLicense https://scigraph.springernature.com/explorer/license/
74 schema:sdPublisher N5b6fff12104c40908c3887ab899c22a0
75 schema:url https://link.springer.com/10.1007%2Fs11060-016-2241-7
76 sgo:license sg:explorer/license/
77 sgo:sdDataset articles
78 rdf:type schema:ScholarlyArticle
79 N001572b6b8aa4e87a0b0670e4d703db1 rdf:first sg:person.016114330577.13
80 rdf:rest Ndb642e2329e2430d81042100fedefaf1
81 N06757b4ac2304d57a498323a897b1d1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Bendamustine Hydrochloride
83 rdf:type schema:DefinedTerm
84 N07987ca76607441fad2e688ba3c2bff6 schema:name dimensions_id
85 schema:value pub.1083842670
86 rdf:type schema:PropertyValue
87 N0da62ab170f948288769e111dc5dedb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Salvage Therapy
89 rdf:type schema:DefinedTerm
90 N2dfbb54b7f4d4c8e8438cbf920a84faf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Temozolomide
92 rdf:type schema:DefinedTerm
93 N2e82a38ee52843a4b8a220aad9edd12a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Male
95 rdf:type schema:DefinedTerm
96 N31364eeee7664aaaa6e7ed33af183ec6 rdf:first sg:person.01261043223.41
97 rdf:rest N001572b6b8aa4e87a0b0670e4d703db1
98 N3ef53c6ca5b149a5a19f33491b89b1d8 schema:name readcube_id
99 schema:value 758cb173f56b40113184fef8e77c79ba619fa19096ba9a6aa1b27f6712dd542e
100 rdf:type schema:PropertyValue
101 N3f7383e6ba1f40748f64d639924d9a3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Dacarbazine
103 rdf:type schema:DefinedTerm
104 N4ab70825768f4557bdd0739fbe538421 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Kaplan-Meier Estimate
106 rdf:type schema:DefinedTerm
107 N4f8d438854bb4dc6a7585f1b155b744e schema:issueNumber 3
108 rdf:type schema:PublicationIssue
109 N501b2fe6bd0c4e11be2108c5ffa065a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Antineoplastic Agents, Alkylating
111 rdf:type schema:DefinedTerm
112 N55333de7ad3544798e6776a91f09dc00 schema:name doi
113 schema:value 10.1007/s11060-016-2241-7
114 rdf:type schema:PropertyValue
115 N5b6fff12104c40908c3887ab899c22a0 schema:name Springer Nature - SN SciGraph project
116 rdf:type schema:Organization
117 N89f9b9fb29554d4d9dfc7a24d81e4bae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Treatment Outcome
119 rdf:type schema:DefinedTerm
120 N90f2e1fdcad049cdbf0debf679ec0f69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Drug Resistance, Neoplasm
122 rdf:type schema:DefinedTerm
123 N917654901e77470693adcee716cf6951 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Neoplasm Recurrence, Local
125 rdf:type schema:DefinedTerm
126 N9314a894c9474a45bda3344f7b4e54c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Glioma
128 rdf:type schema:DefinedTerm
129 Nba6f993506cf4e3da3c70b4fc1e6facf schema:name pubmed_id
130 schema:value 28204914
131 rdf:type schema:PropertyValue
132 Nbd58bb43b0a64950a00bd11eb67424d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Middle Aged
134 rdf:type schema:DefinedTerm
135 Nc5593eac880541d082101a1e80920cb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Brain Neoplasms
137 rdf:type schema:DefinedTerm
138 Ncbf392fe3f4b471fb9c25cbe19258974 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Adult
140 rdf:type schema:DefinedTerm
141 Ncc381f5c09184fcbb384c11656193680 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Humans
143 rdf:type schema:DefinedTerm
144 Nd6380d59460442a0a4ceda1cfbca4de4 rdf:first sg:person.01326261166.36
145 rdf:rest N31364eeee7664aaaa6e7ed33af183ec6
146 Nd9c763ca63df4dc9a57d030959a4a27b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Aged
148 rdf:type schema:DefinedTerm
149 Ndb642e2329e2430d81042100fedefaf1 rdf:first sg:person.010677556177.51
150 rdf:rest rdf:nil
151 Ne31394ef79e5490ea84f2c7e88c7832d schema:name nlm_unique_id
152 schema:value 8309335
153 rdf:type schema:PropertyValue
154 Ne4f8d9eade2e49ffb93c94855dc0fcdc schema:volumeNumber 131
155 rdf:type schema:PublicationVolume
156 Ne836460e828c448da132b04a9896b977 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Female
158 rdf:type schema:DefinedTerm
159 Nf34412bb10504578a9c673b4f8859c02 schema:name Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Cancer Research Center, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Ave E, MS: G4-940, 98109, Seattle, WA, USA
160 rdf:type schema:Organization
161 Nfcd781283a7a4a1caf6d0fc80e5e41c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Prospective Studies
163 rdf:type schema:DefinedTerm
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
168 schema:name Oncology and Carcinogenesis
169 rdf:type schema:DefinedTerm
170 sg:journal.1094205 schema:issn 0167-594X
171 1573-7373
172 schema:name Journal of Neuro-Oncology
173 rdf:type schema:Periodical
174 sg:person.010677556177.51 schema:affiliation https://www.grid.ac/institutes/grid.16753.36
175 schema:familyName Raizer
176 schema:givenName Jeffrey
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51
178 rdf:type schema:Person
179 sg:person.01261043223.41 schema:affiliation https://www.grid.ac/institutes/grid.223827.e
180 schema:familyName Colman
181 schema:givenName Howard
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261043223.41
183 rdf:type schema:Person
184 sg:person.01326261166.36 schema:affiliation Nf34412bb10504578a9c673b4f8859c02
185 schema:familyName Chamberlain
186 schema:givenName Marc C.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
188 rdf:type schema:Person
189 sg:person.016114330577.13 schema:affiliation https://www.grid.ac/institutes/grid.34477.33
190 schema:familyName Kim
191 schema:givenName Bryan T.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016114330577.13
193 rdf:type schema:Person
194 sg:pub.10.1007/978-3-319-12048-5_6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013471351
195 https://doi.org/10.1007/978-3-319-12048-5_6
196 rdf:type schema:CreativeWork
197 sg:pub.10.1007/s00401-007-0243-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001430701
198 https://doi.org/10.1007/s00401-007-0243-4
199 rdf:type schema:CreativeWork
200 sg:pub.10.1007/s00401-014-1370-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000424731
201 https://doi.org/10.1007/s00401-014-1370-3
202 rdf:type schema:CreativeWork
203 sg:pub.10.1007/s11060-008-9722-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029000688
204 https://doi.org/10.1007/s11060-008-9722-2
205 rdf:type schema:CreativeWork
206 sg:pub.10.1007/s11060-011-0612-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050266838
207 https://doi.org/10.1007/s11060-011-0612-7
208 rdf:type schema:CreativeWork
209 sg:pub.10.1007/s11060-014-1411-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046834783
210 https://doi.org/10.1007/s11060-014-1411-8
211 rdf:type schema:CreativeWork
212 sg:pub.10.1007/s11060-014-1714-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051597847
213 https://doi.org/10.1007/s11060-014-1714-9
214 rdf:type schema:CreativeWork
215 sg:pub.10.1038/ng.3273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007363870
216 https://doi.org/10.1038/ng.3273
217 rdf:type schema:CreativeWork
218 sg:pub.10.1038/nrd2596 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034823106
219 https://doi.org/10.1038/nrd2596
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/j.cell.2015.12.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012801617
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/s0140-6736(95)90755-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007598090
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/s1470-2045(14)70011-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046267258
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1056/nejme1506813 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052619643
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1056/nejmoa1402121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034690235
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1056/nejmoa1407279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044684277
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1093/neuonc/nor091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028232474
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1111/bpa.12171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048224406
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1158/1078-0432.ccr-07-1061 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043780748
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1200/jco.1990.8.7.1277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716995
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1200/jco.1999.17.8.2572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549881
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1200/jco.1999.17.9.2762 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549908
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1200/jco.2003.08.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203783
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1200/jco.2003.12.097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204019
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1200/jco.2005.03.4157 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019017095
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1200/jco.2008.18.7252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000657227
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1200/jco.2009.23.6497 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024766199
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1200/jco.2009.25.6941 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045298298
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1200/jco.2009.26.5520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001482068
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1200/jco.2012.43.2229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011620673
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1200/jco.2012.43.2674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044364683
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1200/jco.2013.49.3726 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046571868
264 rdf:type schema:CreativeWork
265 https://doi.org/10.6004/jnccn.2013.0132 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078785484
266 rdf:type schema:CreativeWork
267 https://www.grid.ac/institutes/grid.16753.36 schema:alternateName Northwestern University
268 schema:name Department of Neurology, Northwestern University, Chicago, IL, USA
269 rdf:type schema:Organization
270 https://www.grid.ac/institutes/grid.223827.e schema:alternateName University of Utah
271 schema:name Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
272 rdf:type schema:Organization
273 https://www.grid.ac/institutes/grid.34477.33 schema:alternateName University of Washington
274 schema:name Department of Neurology, University of Washington, Seattle, WA, USA
275 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...